Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margit Fisch

Showing results (291-300 of 336) with videos related to

Pageof 34
Sort By:
International Journal of Radiation Oncology, Biology, Physics|October 30, 2009
Unilateral prostate cancer cannot be accurately predicted in low-risk patientsHendrik Isbarn, Pierre I Karakiewicz, Susanne Vogel, et al.
International Urology and Nephrology|April 2, 2021
Tumor cell PD-L1 expression is a strong predictor of unfavorable prognosis in immune checkpoint therapy-naive clear cell renal cell cancerKatharina Möller, Christoph Fraune, Niclas C Blessin, et al.
International Urology and Nephrology|December 16, 2024
PLAP expression is linked to invasive tumor growth in urothelial carcinoma of the bladderHenning Plage, Kira Furlano, Sebastian Hofbauer, et al.
European Urology Focus|December 18, 2025
Harnessing Artificial Intelligence for Risk Stratification and Outcome Prediction in Urologic Cancers: A Systematic ReviewNavid Roessler, Marcin Miszczyk, Keiichiro Miyajima, et al.
BJU International|August 10, 2023
Urinary function in female patients after traditional, organ-sparing and nerve-sparing radical cystectomy for bladder cancer: a systematic review and pooled analysisEkaterina Laukhtina, Markus von Deimling, Benjamin Pradere, et al.
BMC Urology|February 20, 2025
GATA3 amplification is associated with high grade disease in non-invasive urothelial bladder cancer but unrelated to patient prognosisHenning Plage, Adrian Frericks, Sebastian Hofbauer, et al.
Cancers|December 30, 2025
Differential Androgen Receptor Expression Across Bladder Cancer Stages and Its Link to Poor OutcomesHenning Plage, Nadine Biernath, Kira Furlano, et al.
World Journal of Urology|November 21, 2019
Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancerSimon Kind, Franziska Büscheck, Doris Höflmayer, et al.
Clinical Genitourinary Cancer|May 29, 2017
Effect of Hospital and Surgeon Case Volume on Perioperative Quality of Care and Short-term Outcomes After Radical Cystectomy for Muscle-invasive Bladder Cancer: Results From a European Tertiary Care Center CohortMalte W Vetterlein, Christian P Meyer, Sami-Ramzi Leyh-Bannurah, et al.
Human Pathology|September 24, 2022
GATA3 expression loss is linked to stage progression but is unrelated to prognosis in muscle-invasive urothelial carcinoma of the bladderHenning Plage, Henrik Samtleben, Sebastian Hofbauer, et al.
Pageof 34

Showing results (291-300 of 336) with videos related to

Sort By:
Pageof 34
International Journal of Radiation Oncology, Biology, Physics|October 30, 2009
Unilateral prostate cancer cannot be accurately predicted in low-risk patientsHendrik Isbarn, Pierre I Karakiewicz, Susanne Vogel, et al.
International Urology and Nephrology|April 2, 2021
Tumor cell PD-L1 expression is a strong predictor of unfavorable prognosis in immune checkpoint therapy-naive clear cell renal cell cancerKatharina Möller, Christoph Fraune, Niclas C Blessin, et al.
International Urology and Nephrology|December 16, 2024
PLAP expression is linked to invasive tumor growth in urothelial carcinoma of the bladderHenning Plage, Kira Furlano, Sebastian Hofbauer, et al.
European Urology Focus|December 18, 2025
Harnessing Artificial Intelligence for Risk Stratification and Outcome Prediction in Urologic Cancers: A Systematic ReviewNavid Roessler, Marcin Miszczyk, Keiichiro Miyajima, et al.
BJU International|August 10, 2023
Urinary function in female patients after traditional, organ-sparing and nerve-sparing radical cystectomy for bladder cancer: a systematic review and pooled analysisEkaterina Laukhtina, Markus von Deimling, Benjamin Pradere, et al.
BMC Urology|February 20, 2025
GATA3 amplification is associated with high grade disease in non-invasive urothelial bladder cancer but unrelated to patient prognosisHenning Plage, Adrian Frericks, Sebastian Hofbauer, et al.
Cancers|December 30, 2025
Differential Androgen Receptor Expression Across Bladder Cancer Stages and Its Link to Poor OutcomesHenning Plage, Nadine Biernath, Kira Furlano, et al.
World Journal of Urology|November 21, 2019
Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancerSimon Kind, Franziska Büscheck, Doris Höflmayer, et al.
Clinical Genitourinary Cancer|May 29, 2017
Effect of Hospital and Surgeon Case Volume on Perioperative Quality of Care and Short-term Outcomes After Radical Cystectomy for Muscle-invasive Bladder Cancer: Results From a European Tertiary Care Center CohortMalte W Vetterlein, Christian P Meyer, Sami-Ramzi Leyh-Bannurah, et al.
Human Pathology|September 24, 2022
GATA3 expression loss is linked to stage progression but is unrelated to prognosis in muscle-invasive urothelial carcinoma of the bladderHenning Plage, Henrik Samtleben, Sebastian Hofbauer, et al.
Pageof 34